Story 06/05/23
Reducing ovarian function yields better outcomes for young women with breast cancer
Story 04/21/23
Beyond the headlines: Finances and disparities in breast cancer
Story 04/13/23
Balancing a career and breast cancer: Tiffany’s story
Article
Elacestrant
Ribociclib
Palbociclib
Abemaciclib
Targeted therapy for hormone receptor-positive breast cancer
Story 12/13/22
New breast cancer drug targets AKT pathway
Story 12/09/22
Elacestrant on course to gain FDA approval